Feltl & Co Downgrades ResMed (RMD) to Hold
Tweet Send to a FriendGet Alerts RMD Hot Sheet
Price: $49.43 -1.18%
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade RMD Now!
Feltl & Co downgraded shares of ResMed (NYSE: RMD) from Buy to Hold.
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $32.30 Wednesday, with a 52 week range of $23.37-$35.13.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.
Shares of ResMed closed at $32.30 Wednesday, with a 52 week range of $23.37-$35.13.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: MKM Partners Downgrades Alkermes (ALKS) to Sell
- Jefferies Bumps Zumiez (ZUMZ) Numbers Up, But Remains on Sidelines
- Credit Suisse Downgrades ReneSola Ltd. (SOL) to Underperform
Create E-mail Alert Related Categories
Downgrades
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
